Cancer therapy in mice using a pure population of CD8(+) T cell specific to the AH1 tumor rejection antigen

There is a growing interest in the use of patient-derived T cells for the treatment of various types of malignancies. The expansion of a polyclonal and polyspecific population of tumor-reactive T cells, with a subsequent infusion into the same donor patient, has been implemented, sometimes with posi...

Descripción completa

Detalles Bibliográficos
Autores principales: Stringhini, Marco, Spadafora, Ilaria, Catalano, Marco, Mock, Jacqueline, Probst, Philipp, Spörri, Roman, Neri, Dario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505334/
https://www.ncbi.nlm.nih.gov/pubmed/33796916
http://dx.doi.org/10.1007/s00262-021-02912-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505334/
https://www.ncbi.nlm.nih.gov/pubmed/33796916
http://dx.doi.org/10.1007/s00262-021-02912-9

Ejemplares similares